Rhodiola Rosea for Stress Resilience

Rhodiola is most studied for stress-related fatigue and burnout, where several trials report improved subjective fatigue and stress symptoms over four to eight weeks. Trial quality is limited and objective measures rarely change.

Overview

Verdict

Mixed evidence

How It Works

As an adaptogen, rhodiola is proposed to raise the threshold at which stress produces functional impairment rather than to sedate or stimulate. Salidroside and rosavins modulate HPA-axis output, with animal studies showing blunted corticosterone responses and preserved performance under stressors. Rhodiola also influences monoamine turnover and cellular stress-response proteins, and has been shown to reduce fatigue-related changes in cortisol awakening response in some human work. Reported effects are typically on perceived exertion and fatigue rather than on measurable physical or cognitive capacity.

Dosing & Protocol

Typical dose

Recommended dose: 400-576 mg/day of Rhodiola rosea extract standardised to 3% rosavins and 1% salidroside, taken in the morning
Expected timeframe: 4-12 weeks

Protocol

form: Rhodiola rosea root extract standardised to 3% rosavins and 1% salidroside; SHR-5 extract was used in the main trials
duration: 4 weeks; the burnout trial ran 12 weeks
co factor: Take on an empty stomach in the morning; avoid evening doses. Evidence is mixed. Rhodiola is the adaptogen with the most credible human data, and randomised placebo-controlled trials support reduced fatigue and improved concentration under stress - Olsson found significant improvement over 28 days at 576 mg/day with a reduced cortisol awakening response, Darbinyan found improved performance in night-duty physicians, and Shevtsov found reduced fatigue in cadets under exam stress. Against this, trials are small and short, several involve the same extract manufacturer, resilience is not a validated endpoint, and effects on stress-related outcomes are inconsistent across studies.
titration: Increase to 400 mg/day after a week, up to 576 mg/day split between morning and early afternoon
starting dose: 200 mg in the morning, 30 minutes before breakfast

Evidence

What the studies say

Randomised trials in physicians on night duty, students during examination periods and adults with stress-related fatigue have reported improvements in fatigue scales, perceived stress and self-rated cognitive performance with standardised extract at 200-600mg daily over two to eight weeks. An open-label trial in burnout reported symptom improvement over 12 weeks. A systematic review of rhodiola for fatigue found the trials at high risk of bias, with small samples, inconsistent extract standardisation and heavy reliance on subjective outcomes; objective performance measures frequently show no change. Rhodiola is generally well tolerated but can be activating, and evening dosing may disturb sleep.

A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD)

Score: 3/10

2008

observational

n=10

Bystritsky A, Kerwin L, Feusner JD

Individuals treated with R. rosea showed significant decreases in mean HARS scores at endpoint (t=3.27, p=0.01).

View source

A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue

Score: 7/10

2009

rct

n=60

Olsson EM, von Scheele B, Panossian AG

Significant post-treatment improvements were observed for both groups (placebo effect) in Pines burnout scale, mental health (SF-36), and MADRS, with the SHR-5 group showing greater improvement in burnout and attention.

View source

The effects of Rhodiola rosea L. extract on anxiety, stress, cognition and other mood symptoms

Score: 5/10

2015

rct

n=80

Cropley M, Banks AP, Boyle J

Relative to the controls, the experimental group demonstrated a significant reduction in self-reported, anxiety, stress, anger, confusion and depression at 14 days.

View source

Safety

Caveats

Rhodiola has better evidence than most adaptogens, but the effect is modest and it does not change the load causing the strain - sleep, workload management, exercise, recovery and social support do far more, and psychological therapy addresses the appraisal side that no supplement touches. Safety of rhodiola: generally well tolerated, with dizziness, dry mouth, irritability and insomnia the main effects; doses above 600 mg/day are not better studied and offer no demonstrated advantage. It is activating, so morning dosing only - evening doses disturb sleep and undermine the point. Avoid in bipolar disorder because of reported agitation and possible precipitation of hypomania or mania. Theoretical interactions with MAO inhibitors, SSRIs, SNRIs, triptans and other serotonergic medication mean it should not be combined with these without medical advice, and possible inhibition of CYP3A4 and P-glycoprotein means caution with narrow-therapeutic-index drugs such as ciclosporin, digoxin and warfarin. Adulteration with cheaper Rhodiola species is common, so use third-party tested products. Avoid in pregnancy and breastfeeding, where safety data are absent.

Less likely to help if

People with bipolar disorder, and anyone whose exhaustion has an untreated medical cause.

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.